Inflammatory Diseases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Inflammatory Diseases stocks.

Inflammatory Diseases Stocks Recent News

Date Stock Title
May 13 VTYX Ventyx Biosciences, Inc. (NASDAQ:VTYX) Q1 2024 Earnings Call Transcript
May 13 RVPH Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference
May 13 CANF Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study
May 12 RAPT Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
May 11 VTYX Ventyx Biosciences, Inc. (VTYX) Q1 2024 Earnings Call Transcript
May 10 RAPT RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview
May 10 RAPT RAPT falls for second day as Guggenheim, Barclays downgrade stock
May 10 CANF Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 10 CANF Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial
May 9 RAPT What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
May 9 VTYX Ventyx Biosciences GAAP EPS of -$0.62 beats by $0.05
May 9 VTYX Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress
May 9 RAPT RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials
May 9 RAPT RAPT Therapeutics plunges 40% as it ends phase 2 study of lead asset zelnecirnon
May 9 RAPT RAPT Therapeutics GAAP EPS of -$0.79
May 9 CANF Can-Fite stock up on FDA IND clearance for namodenoson to treat MASH patients in mid-stage study
May 9 RVPH Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
May 9 RAPT RAPT Therapeutics Reports First Quarter 2024 Financial Results
May 9 CANF Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study
May 9 APLS Analysts Are Updating Their Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Estimates After Its First-Quarter Results
Inflammatory Diseases

Inflammatory diseases are a group of disorders that involve the body's immune system. These diseases can affect any part of the body, including the skin, joints, lungs, heart, and blood vessels. Common inflammatory diseases include rheumatoid arthritis, lupus, inflammatory bowel disease, and psoriasis. Symptoms of inflammatory diseases vary depending on the type of disease, but can include joint pain, swelling, fatigue, fever, and skin rashes. Treatment for inflammatory diseases typically involves medications to reduce inflammation and suppress the immune system.

Browse All Tags